换一批
换一批Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy.
第一作者：
Ya-Zhen,Qin
第一单位：
a Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation , Beijing , China.
作者：
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);染色体畸变(Chromosome Aberrations);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);癌基因蛋白质类, 融合(Oncogene Proteins, Fusion);预后(Prognosis);原癌基因蛋白质类c-kit(Proto-Oncogene Proteins c-kit);缓解诱导(Remission Induction);转录, 遗传(Transcription, Genetic);移植, 同种(Transplantation, Homologous);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.3109/10428194.2015.1032964
PMID
25804769
发布时间
2019-01-16
- 浏览135
Leukemia & lymphoma
3116-23页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
